论文部分内容阅读
前不久,一篇文章的标题特别醒目:《生物制药业呼唤张朝阳》,从这一“呼唤”中人们可以解读出我国高科技产业化人才奇缺。近年来,我国每年产生科技成果3万多项,但转化成生产力的只有10%强。据统计,1981年至1998年间,我国共用1013亿美元买进27619项技术,而这些技术全部来自发达国家的企业。知本与资本链接不畅、科技成果转化率低呼唤大批高科技产业化人才加盟。作为“科技兴国”、“科技创新”的排头兵,高科技产业化人才无疑是我国21世纪的“金领”。高科技管理人才市场渴求美国克里夫兰战略中心最近的调查表明,在发展高技术产品比较集中的300家美国大企业中,60%存
Not long ago, the title of an article was particularly eye-catching: “The biopharmaceutical industry called for Zhang Zhaoyang,” and from this “call” one can interpret the scarcity of high-tech industrialized professionals in our country. In recent years, China has produced more than 30,000 scientific and technological achievements each year, but only 10% of those transformed into productive forces are strong. According to statistics, between 1981 and 1998, China bought a total of 107,600 items of technology worth 101.3 billion U.S. dollars, all of which came from enterprises in developed countries. Poor access to capital and capital, low conversion rate of scientific and technological achievements call for a large number of high-tech industrialization talent to join. As the vanguard of “rejuvenating the country through science and technology” and “technological innovation,” the high-tech industrialized personnel are undoubtedly the “golden collar” in the 21st century in our country. The Thirst for High-tech Management Talent Market Recent surveys conducted by the Cleveland Center for Strategic Studies show that 60% of the 300 U.S. large-scale enterprises that concentrate their high-tech products are